CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 8 No. 5
 

Careful and Correct Coding Crucial for Oncology Practices to Avoid Triggering a Medicare Audit

May 1, 1999

ALEXANDRIA, Virginia—Careful and correct coding has become crucial for oncology practices that wish to maximize reimbursement and minimize their chances of a Medicare audit, said Roberta Lee Buell, MBA, president and chief executive officer of Intake Initiatives, Inc./Documedics, San Bruno, California.

Coding issues have become so complex that “everyone will be audited, at least on a prepayment basis,” she said at the 25th Annual Meeting of the Association of Community Cancer Centers.

Ms. Buell’s expertise on oncology coding issues is so widely recognized that session chairman John E. Feldmann, MD, of the Mobile Infirmary Medical Center, Mobile, Alabama, introduced her as the “code mistress.”

Unlike other areas of law, where fraud is generally defined as the willful intent to deceive, Ms. Buell emphasized that in Medicare reimbursement, fraud is defined as “reckless disregard” for the current rules of coding.

“This means that innocent mistakes are frequently audited and investigated as potential fraud, and a single line item can trigger a fine of up to $10,000,” Ms. Buell said, adding that “this is where Medicare is deriving a lot of its revenue these days.”

Avoiding accusations of reckless disregard requires that all oncology prac-tices and hospital oncology services establish procedures that attempt to assure that their coding complies with the rules. This requires educating the entire staff about the realities of a rapidly changing, but often misunderstood, field. Sources of confusion are legion, she warned, because the definitions of the various codes are extremely precise, and the requirements for documentation are strict.

For example, to bill for a relatively lucrative physician consult as opposed to an intake visit, which is reimbursed at a lower rate, the consulting physician must meet three requirements: the physician must not yet have decided to treat the patient, must have sent a written report to the patient’s primary care physician, and must not have initiated treatment prior to completing the consult.

If these conditions cannot be met, she advised, the wise course is to “bite the bullet” and code for a lower-paid initial visit rather than for a consult. Ms. Buell believes that consults are triggering many audits.

“Nursing services must also be scrupulously documented,” she said. To avoid trouble, for example, practices should use really good chemotherapy flow sheets and carefully document physician supervision of nurses.

In initiating audits, Medicare looks for “aberrant behaviors” such as excessive use of a single code, billing drugs at higher rates than other practices in the area, excessive use of lab work, and such irregularities in clinical trials as billing drugs or patient management fees that were paid by the trial’s sponsor.

“It is important,” she explained, “that clinical trial contracts specify that the sponsor pays the practice for managing data, not people.” She also cautioned that using a single code for all office visits constitutes “reckless disregard.” In addition, she strongly advised staying in touch with local medical societies to keep abreast of which issues Medicare is auditing at any given time.

Three Levels of Audits

Medicare has three levels of audits: prepayment reviews; fair hearings, which may involve writing a letter, talking on the phone, or appearing in person; and hearings before an administrative law judge. “It is vital that those being investigated understand and use their right of appeal,” she said.

She reassured the audience that “every audit does not imply a suspicion of fraud” and that a number of resources exist to help practices during audits. “Professional organizations are particularly good sources of advice,” she said, adding that successful resolution of an audit need not require a lawyer if the practice has carefully documented its activities and followed the rules.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy